Esra Terzi Demirsoy

8PUBLICATIONS
87CO-AUTHORS
Haematological tumoursHaematologyPredictive and prognostic markersTe urupare me te whai wāhi Māori ki te mātauranga (Māori responsiveness and engaged education)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 27, 2026
Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

|Oct 16, 2025
Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group.

Emel Isleyen, Nurcan Alhan, Esra Terzi Demirsoy

|Mar 01, 2024
Do Alarmins Have a Role in Multiple Myeloma?

Ayfer Gedük, Merve Gökçen Polat, Esra Terzi Demirsoy

|Nov 14, 2023
Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz

|Jun 12, 2023
Correction to: Efects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma.

Ayfer Geduk, Berrin Oztas, Baldan Huri Eryılmaz

|Apr 03, 2023
Effects of AGEs, sRAGE and HMGB1 on Clinical Outcomes in Multiple Myeloma.

Ayfer Geduk, Berrin Oztas, Baldan Huri Eryılmaz

Pageof 2

Frequent Collaborators

6 joint publications

Ayfer Geduk

5 joint publications

Özgür Mehtap

4 joint publications

Hasim Atakan Erol

4 joint publications

Abdullah Hacıhanefioğlu